Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Argentina Lithium Exercises Property Options at Rincon West and Antofalla North (click to learn more) Heritage Mining - Drill Program Update and Planned Alcona Phase II Drill Program (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Quest Pharmatech Inc V.QPT

Alternate Symbol(s):  QPTFF

Healthcare Biotechnology
Quest PharmaTech Inc. is a Canadian biopharmaceutical company. The Company is developing products to improve the quality of life. It is developing the proprietary, MAb-AR9.6, targeting MUC16 as a diagnostic agent for cancer. MAb-AR9.6 is licensed from the University of Nebraska Medical Centre and is in late preclinical stage development. The Company has a 42.5% ownership interest in OncoQuest... see more

Recent & Breaking News (TSXV:QPT)

Quest PharmaTech Provides Corporate Update

Canada NewsWire September 13, 2023

Quest PharmaTech Announces Results from AGM

Canada NewsWire July 14, 2023

Quest PharmaTech Provides Product Development Update

Canada NewsWire July 10, 2023

Quest PharmaTech Provides Corporate Update

Canada NewsWire June 9, 2023

Canadian Investment Regulatory Organization Trade Resumption - QPT

Canada NewsWire June 7, 2023

Quest PharmaTech Clarifies Agreement in Principle with OQP Bio Inc.

Canada NewsWire June 6, 2023

Canadian Investment Regulatory Organization Trading Halt - QPT

Canada NewsWire June 6, 2023

Quest PharmaTech Provides Corporate Update

Canada NewsWire June 2, 2023

Quest PharmaTech Announces Sale of Bioceltran Investment and Return of Photodynamic Therapy Technology License

Canada NewsWire September 28, 2022

Quest PharmaTech Announces Results from AGM

Canada NewsWire July 21, 2022

Quest PharmaTech Provides Corporate Update

Canada NewsWire April 19, 2022

OncoQuest Pharmaceuticals Inc. Announces First Patient Enrolled in Each of Two Investigator Initiated Clinical Trials of Oregovomab in Combination Therapy for the Treatment of Recurrent Ovarian Cancer

PR Newswire September 1, 2021

Quest PharmaTech Announces Results from AGM

PR Newswire July 7, 2021

Quest PharmaTech announces two presentations by OncoQuest Pharmaceuticals, Inc. at the 2021 Annual Meeting of the American Association of Clinical Oncologists

Canada NewsWire June 1, 2021

Quest Provides Update to Immunotherapy Asset Transfer Between OncoQuest Inc. and OncoQuest Pharmaceuticals Inc.

Canada NewsWire March 26, 2021

Quest Provides Update to Immunotherapy Asset Transfer Between OncoQuest Inc. and OncoQuest Pharmaceuticals Inc.

Canada NewsWire February 2, 2021

Quest Provides Update to Immunotherapy Asset Transfer Between OncoQuest Inc. and OncoQuest Pharmaceuticals Inc.

Canada NewsWire January 5, 2021

Quest Announces that OncoQuest Pharmaceuticals Inc. Doses First Patient in Phase 3 Clinical Trial, FLORA-5, of Company's Lead Investigational Drug, Oregovomab, in Frontline Ovarian Cancer and appoints Dr. Sunil Gupta as Chief Medical Officer

Canada NewsWire November 9, 2020

Quest Provides Corporate Update

Canada NewsWire June 4, 2020

IIROC Trading Resumption - QPT

Canada NewsWire June 2, 2020